Applied Research in Health Services
Publications (9) Publications in which a researcher has participated
filter_list
Allergy and Immunology
2025
-
Comparative evaluation of point of care assay with ELISA techniques for quantifying serum concentrations of ustekinumab in inflammatory bowel disease patients
Gastroenterologia y Hepatologia, Vol. 48, Núm. 6
2024
-
Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study
Gastroenterologia y Hepatologia, Vol. 47, Núm. 6, pp. 553-561
2023
-
Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease
Gastroenterologia y Hepatologia, Vol. 46, Núm. 7, pp. 504-511
2021
-
Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 113, Núm. 11, pp. 770-775
2020
-
Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease
International Journal of Clinical Pharmacy, Vol. 42, Núm. 2, pp. 500-507
-
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients
Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 8, pp. 590-597
-
Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease ORIGINAL PAPERS
Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 5, pp. 360-366
2016
-
Effect of drug interactions involving antiretroviral drugs on viral load in HIV population
European Journal of Hospital Pharmacy , Vol. 23, Núm. 4, pp. 241-243
2015
-
Identification of potential clinically significant drug interactions in HIV-infected patients: A comprehensive therapeutic approach
HIV Medicine, Vol. 16, Núm. 5, pp. 273-279